TrialSignal
Clinical trial intelligence report
Promote Q CRT-D and Quartet Left Ventricular Heart Lead Study
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT00990665
Status
COMPLETED
Phase
NA
Sponsor
Abbott Medical Devices
Executive brief
Investment-Ready Snapshot
The Promote Q CRT-D and Quartet LV lead study, sponsored by Abbott Medical Devices, aimed to evaluate the safety and efficacy of a new cardiac resynchronization therapy device in patients with heart failure. The study enrolled 178 participants and was completed in July 2012.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00990665
Indication
Heart Failure
Modality
medical device
Target
Heart Failure
Intervention
CRT-D and LV lead (Quartet™ lead and Promote Q® device system)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.